{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:28:20Z","timestamp":1790911700699,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.ijantimicag.2011.02.001","type":"journal-article","created":{"date-parts":[[2011,4,15]],"date-time":"2011-04-15T17:12:52Z","timestamp":1302887572000},"page":"547-549","source":"Crossref","is-referenced-by-count":16,"title":["Comparative in vitro susceptibility of Burkholderia pseudomallei to doripenem, ertapenem, tigecycline and moxifloxacin"],"prefix":"10.1016","volume":"37","author":[{"given":"Patrick","family":"Harris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Engler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Norton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2011.02.001_bib0005","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0035-9203(08)70002-6","article-title":"The global distribution of Burkholderia pseudomallei and melioidosis: an update","volume":"102","author":"Currie","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.ijantimicag.2011.02.001_bib0010","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0140-6736(03)13374-0","volume":"361","author":"White","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2011.02.001_bib0015","doi-asserted-by":"crossref","first-page":"335","DOI":"10.4269\/ajtmh.2009.81.335","article-title":"Patterns of organ involvement in recurrent melioidosis","volume":"81","author":"Limmathurotsakul","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ijantimicag.2011.02.001_bib0020","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twentieth informational supplement. Document M100-S20. Wayne, PA: CLSI; 2010."},{"key":"10.1016\/j.ijantimicag.2011.02.001_bib0025","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/QCO.0b013e32833fb88c","article-title":"Melioidosis: advances in diagnosis and treatment","volume":"23","author":"Cheng","year":"2010","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.02.001_bib0030","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0140-6736(89)90768-X","article-title":"Halving of mortality of severe melioidosis by ceftazidime","volume":"2","author":"White","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2011.02.001_bib0035","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/jac\/37.3.611","article-title":"In-vitro activity of carbapenem antibiotics against \u03b2-lactam susceptible and resistant strains of Burkholderia pseudomallei","volume":"37","author":"Smith","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.02.001_bib0040","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1128\/AAC.48.8.2999-3005.2004","article-title":"Comparison of the susceptibilities of Burkholderia pseudomallei to meropenem and ceftazidime by conventional and intracellular methods","volume":"48","author":"Inglis","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.02.001_bib0045","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/j.1469-0691.2005.01271.x","article-title":"Antimicrobial activity of doripenem (S-4661): a global surveillance report (2003)","volume":"11","author":"Fritsche","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2011.02.001_bib0050","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/jac\/28.2.321","article-title":"Development of resistance to ceftazidime and co-amoxiclav in Pseudomonas pseudomallei","volume":"28","author":"Dance","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.02.001_bib0055","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0924-8579(00)00334-4","article-title":"Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis","volume":"17","author":"Jenney","year":"2001","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2011.02.001_bib0060","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1080\/00365540701402988","article-title":"Burkholderia pseudomallei: in vitro susceptibility to some new and old antimicrobials","volume":"39","author":"Karunakaran","year":"2007","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.02.001_bib0065","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1128\/AAC.00893-08","article-title":"In vitro activity of doripenem against Burkholderia pseudomallei","volume":"53","author":"Thamlikitkul","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.02.001_bib0070","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/jac\/dkq044","article-title":"Stability of meropenem and doripenem solutions for administration by continuous infusion","volume":"65","author":"Berthoin","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.02.001_bib0075","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1128\/AAC.01843-09","article-title":"Pharmacokinetic\u2013pharmacodynamic-model-guided doripenem dosing in critically ill patients","volume":"54","author":"Samtani","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.02.001_bib0080","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ijantimicag.2008.08.031","article-title":"Pharmacokinetic\u2013pharmacodynamic target attainment analysis of doripenem in infected patients","volume":"33","author":"Ikawa","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2011.02.001_bib0085","unstructured":"British Society for Antimicrobial Chemotherapy. BSAC methods for antimicrobial susceptibility testing. Birmingham, UK: BSAC; 2010. http:\/\/www.bsac.org.uk\/Resources\/BSAC\/Version_9.1_March_2010_final.pdf [accessed 20 November 2010]."},{"key":"10.1016\/j.ijantimicag.2011.02.001_bib0090","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4269\/ajtmh.2001.64.24","article-title":"Maintenance therapy of melioidosis with ciprofloxacin plus azithromycin compared with cotrimoxazole plus doxycycline","volume":"64","author":"Chetchotisakd","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ijantimicag.2011.02.001_bib0095","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0035-9203(97)90044-4","article-title":"Oral fluoroquinolones for maintenance treatment of melioidosis","volume":"91","author":"Chaowagul","year":"1997","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.ijantimicag.2011.02.001_bib0100","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.2165\/00003495-200565180-00008","article-title":"Tigecycline","volume":"65","author":"Frampton","year":"2005","journal-title":"Drugs"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857911000793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857911000793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T23:06:10Z","timestamp":1560121570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857911000793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0924857911000793"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2011.02.001","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}